123-Iodine MIBG in the Assessment of Sympathetic Denervation in Ogilvie's Syndrome

123-Iodine MIBG in the Assessment of Sympathetic Denervation in Ogilvie's Syndrome

123-Iodine metaiodobenzylguanidine (I-123 MIBG) imaging is frequently used in the assessment of sympathetic innervation and autonomic dysfunction in patients with cardiac failure, neurodegenerative Parkinson's syndrome, multiple system atrophy, myotonic dystrophy, and diabetic mellitus. The eti...

Full description

Saved in:
Bibliographic Details
Main Authors: Amit Bhoil, Sobhan Vinjamuri
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-09-01
Series:World Journal of Nuclear Medicine
Subjects:
i-123 mibg
autonomic neuropathy
ogilvie's syndrome
pseudo-obstruction
sympathetic dysfunction
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1750387
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:123-Iodine metaiodobenzylguanidine (I-123 MIBG) imaging is frequently used in the assessment of sympathetic innervation and autonomic dysfunction in patients with cardiac failure, neurodegenerative Parkinson's syndrome, multiple system atrophy, myotonic dystrophy, and diabetic mellitus. The etiology of pseudo-obstruction remains unknown with likely imbalance between sympathetic and parasympathetic innervation proposed as a hypothesis. We present a case demonstrating the utility of I-123 MIBG scintigraphy for evaluating a case of pseudo-obstruction requiring frequent hospitalization due to progressive complex autoimmune neurological disorder.
ISSN:1450-1147
1607-3312

Similar Items